European Antibiotic Awareness Day
In times of COVID-19, don’t give up on antimicrobial resistance (AMR) and stay united to preserve antimicrobials!Find out more
On any given day 1 in 3 patients received at least one antimicrobial
Some of this use may be unnecessary and lead to the spread of antimicrobial resistance.ECDC point-prevalence surveys
Latest antimicrobial resistance data
Interactive reports with the latest data in Europe in the ECDC Surveillance AtlasView Atlas
Directory of online resources
The directory lists strategies, guidance documents and training courses on the prevention and control of antimicrobial resistance and healthcare-associated infections available online.View web directory
Assessment tool for joint One Health country visits in relation to antimicrobial resistance
Risk Assessment: Emergence of hypervirulent Klebsiella pneumoniae ST23 carrying carbapenemase genes in EU/EEA countries
Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant acinetobacter baumannii in Europe, 2019
Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?
External quality assessment (EQA) of performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net), 2019
Sidestepping antimicrobial resistance: the role of existing and new antibiotics – event at the European Parliament
Threats and outbreaks
Risk assessments and rapid risk assessments related to the spread or occurrence of highly antibiotic-resistant bacteria
Systematic reviews, expert opinions and public health guidance on antimicrobial resistance
Communication toolkits for the European Antibiotic Awareness Day offer template campaigns materials promoting responsible use of antibiotics
Antimicrobial resistance in specific diseases
Antimicrobial resistance - Escherichia coli
Escherichia coli resistance to major antibiotics is increasing in almost all countries in Europe. E. coli causes urinary tract and more serious infections and is one of the most common bacteria causing infections.
Antimicrobial resistance - Tuberculosis
In EU, only 1 in every 3 MDR TB patients has a successful treatment outcome; more than half either die, fail treatment or default (stop taking treatment). XDR TB has even worse treatment outcomes: only 1 in 4 patients finishes treatment successfully.
Antimicrobial resistance - Salmonellosis
Multi-drug resistant Salmonella bacteria continue to spread across Europe, show the latest data on resistance in bacteria in humans, food and animals issued by ECDC and EFSA. There’s evidence of resistance to the antimicrobial colistin in Salmonella among poultry in the EU - this last-resort drug may soon no longer be effective for treating severe human infections with Salmonella.
Antimicrobial resistance/ microbiology - Gonorrhoea
The surveillance of gonococcal antimicrobial susceptibility surveillance in Europe is essential for detecting emerging and increasing antimicrobial resistance and making quality-assured data available to inform revisions of treatment guidelines. ECDC coordinates the Euro-GASP network.
Cross-border spread of blaNDM-1- And blaOXA-48 positive Klebsiella pneumoniae: A European collaborative analysis of whole genome sequencing and epidemiological data, 2014 to 2019
Antimicrobial resistance in Neisseria gonorrhoeae isolates from foreign-born population in the European Gonococcal Antimicrobial Surveillance Programme